Codasip and onsemi: chip IP, public funding and control

Onsemi’s acquisition of part of Codasip raises a legitimate question about the long-term value of publicly supported European chip development. Answering it requires following the specific intellectual property, funding obligations and engineering capability that changed hands.

A Czech chip-design business, substantial European public support and an American buyer: the ingredients invite a simple story about valuable technology leaving Europe at a bargain price.

The public documents tell a more specific story. Onsemi completed the acquisition of a RISC-V processor IP business from Codasip s.r.o. on 4 May 2026. Its regulatory filing puts the total cash consideration at up to $14.5 million. Codasip described the transaction as a divestiture of its lower-end processor design business, alongside a broad licence to its Studio design tool. It also announced a continuing focus on secure computing. Onsemi’s SEC filing, Note 4, Codasip’s transaction announcement

The Czech reporting saved for this analysis puts public funding and the apparent acquisition price under scrutiny. That is an important starting point. It does not, by itself, establish how much support funded the transferred assets or whether the transaction breached any funding conditions. Original reporting by Živě

For international companies considering Czech R&D partnerships, the case is useful beyond the controversy. It shows why a capable local engineering team, ownership of a design, permission to use a tool and control of future product decisions must be examined separately.

What onsemi actually disclosed

Onsemi’s quarterly report for the period ended 3 July 2026 describes an acquisition of rights to Codasip’s RISC-V processor IP enterprise. It accounts for the transaction as a business combination and identifies processor cores, Studio electronic design automation tools, supporting intellectual property and an organised workforce as elements intended to accelerate its computing capabilities.

The price has an important qualification. The maximum $14.5 million includes $1.45 million withheld, payable upon IP acceptance and completion of a contractual defect-remediation period. The filing therefore does not describe an unconditional $14.5 million already paid in full. It also does not establish a valuation for the entire Codasip group. Onsemi’s acquisition disclosure

Codasip’s announcement adds a useful distinction: the buyer received a broad Studio licence. A licence can provide substantial commercial freedom, but its existence does not establish that ownership of the whole Studio platform transferred. The public announcement does not disclose the complete licence terms, exclusivity provisions or allocation of every associated right. Codasip’s announcement of 8 April 2026

Sources for the transaction table: onsemi’s SEC report and Codasip’s announcement.

Why an open architecture still has valuable IP

RISC-V is an open instruction set architecture: the specification that defines the instructions software can ask a compatible processor to execute. RISC-V International explicitly distinguishes that open standard from the implementations built around it, which may be open or proprietary. RISC-V International’s explanation

That distinction matters commercially. Access to an instruction set does not supply a finished, verified processor design, a complete development toolchain or a team that can adapt the design to a customer’s requirements. Those capabilities can still be developed, licensed and acquired as commercial assets.

A useful analogy is a shared technical language. Knowing the language allows engineers to build compatible products; it does not make every product design written in that language freely available.

Codasip’s Studio tool is relevant because it supports processor development and customisation. The acquisition therefore concerns more than a familiar architecture name. Onsemi’s disclosure expressly includes tools, supporting IP and people. The commercial question is how those elements work together and who can use, maintain and develop them after the deal. Codasip’s description of its product areas, onsemi’s acquisition disclosure

Public funding: several different numbers are being discussed

Public support is central to this story. However, grants, equity investments, project budgets and possible future financing measure different things.

When Codasip launched its accelerated sale process in July 2025, it said it had been awarded more than €119 million in grants and equity funding from EU and national bodies. Crucially, the company said most of that amount was still to be received. It separately estimated another €210 million from follow-on grant phases and referred to additional potential financing from new projects. These were company statements about funding and prospects at that time, rather than an audited total of cash spent on the business subsequently sold. Codasip’s July 2025 sale announcement

Official project records offer a more granular view. They identify different legal entities and different research programmes. The table below deliberately keeps those records separate.

Sources: Codasip’s sale announcement, CORDIS 881172, CORDIS 190101116, CORDIS DARE SGA1.

These rows should not be added to the €119 million headline: project amounts may already be included in that broader statement. Nor should they be subtracted from the purchase price to manufacture a taxpayer-loss figure. The currencies, beneficiaries, instruments, dates and asset scope differ.

Codasip’s public funding page also identifies Czech and European programmes beyond these examples. Establishing a complete funding history would require reconciling those programmes, payments, beneficiary entities and the research outputs they financed. Codasip’s European support overview

What would establish whether the public received value?

A relatively small acquisition price alongside substantial public support deserves scrutiny. The missing step is tracing the support to the results and rights concerned.

An assessment would need to establish:

• Which funded projects contributed to the transferred processor designs, tools or know-how.
• How much funding was actually paid, and to which legal entity.
• Which research outputs and exploitation obligations remained with Codasip after the sale.
• Whether the relevant funding agreements required notification, consent, continued access or other conditions when rights changed hands.
• What the funding authorities approved and whether any repayment or other adjustment arose.
• How the sale process established a price for the particular business being transferred.

Those are questions for the agreements, transaction documents and responsible authorities. The public sources reviewed here do not establish either a funding violation or a clean bill of health for every programme.

There is also a wider policy issue. Publicly funded research can create useful technology and skilled employment while commercial control changes. Whether that meets a programme’s objectives depends on the objectives themselves: research delivery, continued European access, industrial exploitation, financial return or another specified outcome.

Our view is that the strongest accountability question concerns what rights and capabilities the funding secured over time. A headline comparison between a funding total and an asset-sale price cannot answer it.

What Codasip says it will develop next

The remaining business is part of the story. In April 2026, Codasip announced that it would expand its CHERI-enabled processor IP offering and develop secure systems-on-chip and FPGA solutions. CHERI adds capability-based protection intended to address memory-safety problems. These are company plans and technical intentions, not a guarantee that a system cannot be compromised. Codasip’s strategic pivot announcement

High-performance computing is another distinct development track. In March 2025, Codasip announced its role in designing a general-purpose processor for DARE. That announcement referred to €240 million for the initiative’s first three-year phase. It did not say that the entire amount belonged to Codasip. The CORDIS participant records provide the more specific entity-level contribution figures shown above. Codasip’s DARE announcement, DARE SGA1 project record

For customers and prospective partners, the practical follow-up is product-specific. Ask which organisation is responsible for a particular core, which development team supports it and which roadmap is contractually available. A corporate strategy announcement cannot substitute for those answers.

Czech engineering, European funding and American ownership

The geography is more complex than a Czech-versus-American headline suggests. Onsemi identifies Codasip s.r.o. as the seller in the transaction. European project records separately identify the German Codasip GmbH and Czech Codasip s.r.o.; the EIC Fund also lists Codasip GmbH in its portfolio. Onsemi’s filing, CORDIS project record, EIC Fund portfolio

For a business decision, separate the place where engineers work, the entity signing a licence, the owner of the relevant IP and the organisation controlling future product investment. They may overlap, but a Czech development address alone does not answer all four questions.

The same care applies to onsemi’s Rožnov manufacturing investment, which Kodo has covered separately. A processor-design acquisition and a semiconductor factory expansion involve different assets, funding arrangements and commercial decisions. This acquisition should not be treated as confirmation that the separate factory project will proceed on a particular schedule. Kodo’s Rožnov analysis

What international partners should verify

For European, Taiwanese and other international semiconductor businesses considering Czech development partners, this case suggests a practical way to prepare discussions.

Start with the exact product and contracting entity. Record the core or tool version, licence holder, support provider and party entitled to grant the rights your product needs. Ask how a business transfer affects an existing agreement.

Test continuity alongside technical performance. A capable processor design is useful only if the project can obtain maintenance, documentation, development-tool access and a workable route for future changes. Request evidence for those commitments during partner evaluation.

Map public-project obligations before relying on access to results. Participation in a European programme does not, by itself, establish that another company can freely use every resulting design. Qualified advisers should examine the applicable agreements and access rights.

Keep commercial qualification specific. A company-wide reputation or a broad reference to automotive capability does not establish that your chosen configuration meets a customer’s requirements. Tie the evidence to the product, intended application and buyer’s approval process.

Compare location with control. Local engineering capacity can be valuable for collaboration. For a long-term product programme, also establish who can authorise design changes, commit resources and determine whether the product remains available.

These steps help turn an attractive Czech technology opportunity into a partnership that can be assessed on its actual terms.

The main conclusion

Onsemi’s filing confirms a completed acquisition and a price of up to $14.5 million. Codasip’s announcement narrows the business scope and identifies a broad Studio licence alongside a continuing secure-computing strategy. Official records also demonstrate significant public participation across distinct projects and entities.

Together, these facts justify a serious discussion about ownership, industrial policy and accountability. They do not establish that the entire Codasip business, or every publicly supported research result, was sold for that price.

For public oversight, follow the funded outputs and their contractual obligations. For a prospective customer or partner, follow the specific licence, engineering team and product roadmap. Both approaches require more detail than the headline provides.

How Kodo can help

Kodo helps international technology and industrial companies prepare the commercial and operational side of entering Czechia. We support early market validation, partner mapping, local positioning, English and Czech communication, web content and coordination of the first implementation steps.

For legal, intellectual-property, regulatory, certification and investment-incentive matters, companies should work with qualified specialists and the responsible authorities.

Contact Kodo

---

Related reading

• Onsemi’s Rožnov investment faces a deeper reset
• ESMC in Dresden: what Czech suppliers need to qualify
• Why international certification is often the real barrier to European supply chains

Sources

• Onsemi: Form 10-Q for the quarter ended 3 July 2026, Note 4 — Acquisitions and Divestitures
• Codasip: strategic pivot and divestiture, 8 April 2026
• Codasip: board initiates an expedited sale process, 1 July 2025
• European Commission CORDIS: RISC-V Digital Architecture, project 881172
• European Commission CORDIS: high-end processor IP and design tools, project 190101116
• European Commission CORDIS: DARE SGA1, project 101202459
• Codasip: participation in DARE, 6 March 2025
• Codasip: European and Czech public-support programmes
• European Innovation Council: Codasip GmbH portfolio entry
• RISC-V International: the open ISA and proprietary implementations
• Živě: original Czech reporting that prompted this analysis — public introduction

Based on public information reviewed on 24 October 2026. This article provides general market and supply-chain analysis, not legal, intellectual-property or investment advice. The available disclosures do not constitute a complete funding audit or an independent valuation of the transaction.